|
|
Article: Acting FDA Commissioner von Eschenbach Headlines Windhover's ``FDA/CMS Summit for Biopharma Executives''; New FDA Leader's First Major Industry Address.
- Article from:
- Business Wire
- Article date:
- October 31, 2005
CopyrightCOPYRIGHT 2005 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
NORWALK, Conn. -- Andrew von Eschenbach, MD, newly appointed Acting Commissioner of the Food and Drug Administration (FDA), will deliver a keynote speech at Windhover Information Inc.'s FDA/CMS Summit for Biopharma Executives on Thursday, December 1, 2005, at The Mayflower Hotel, Washington, D.C. von Eschenbach's speech will focus on the top FDA issues likely to affect the biotechnology and pharmaceutical industries in 2006.
Dr. von Eschenbach's address to the top senior biopharma executives will be one of his first major speeches in his new role as head of FDA. Industry leaders will have an opportunity to hear first hand how Dr. von Eschenbach plans to approach ...